The PI3K/AKT/TOR pathway is of particular interest because mutations in all components of the pathway are common in various solid tumors [7] and because rapamycin itself extends life and diminishes the incidence of cancer in numerous strains of mice [8,9,10]. The gene discussed is RORC; the disease is cancer.